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Abstract
Determination of carboxyhemoglobin (HbCO) is routinely performed in suspected
cases of carbon monoxide intoxication and unexplained deaths. However, some
authors have suggested that measured HbCO may be falsely elevated in infants (0–
12 months) due to the presence of fetal hemoglobin (HbF). The purpose of this study
was to evaluate the impact of fetal hemoglobin on the spectrophotometric determina-
tion of carboxyhemoglobin. The interference of HbF in the determination of HbCO
in infants aged from 0 to 12 months was evaluated using 16 ante-mortem and 19
post-mortem blood samples. The %HbCO was quantified spectrophotometrically by
calculating the 560 nm/530 nm absorbance ratio, using a dual beam spectrophotome-
ter. The average measured HbCO in infants of 3 months of age or under was 17%,
which is abnormally elevated. No significant difference in HbCO measurement was
found between ante-mortem and post-mortem samples. These results highlight the
fact that care must be taken in interpretation of carboxyhemoglobin measurements
in infants when using a spectrophotometric method.
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1 INTRODUCTION
Carbon monoxide (CO) is a gaseous product of the incomplete combustion of organic matter such as wood or fuel. When CO is
inhaled, it binds with hemoglobin (Hb) to form carboxyhemoglobin (HbCO). Hemoglobin has an affinity for CO that is 250 times
larger than oxygen (O2); therefore, at high CO levels, hemoglobin cannot accomplish its oxygen delivery duties
1. Although the
mechanisms are not completely understood, myoglobin, cytochromes and chemical mediators are also suspected to be involved
in CO toxicity2. Levels of HbCO up to 10% in smokers are considered normal, whereas levels between 20% and 50% are toxic
and levels above 50% are lethal3. Carbon monoxide intoxication is typically observed in cases of residential or commercial
fires, industrial accidents, heating systems (oil, propane, fireplaces) and suicide through car exhaust inhalation. HbCO can be
quantified in blood by gas chromatography, with an oxygen electrode, or by obtaining the absorption spectrum using a spec-
trophotometer4 or a CO-oximeter5. The spectrophotometric measurement is very popular because it is simple, accurate, rapid
and accessible6. However, it is reported that spectrophotometric measurement of HbCO can be subject to interferences from
fetal hemoglobin (HbF)7,8. Fetal hemoglobin is structurally similar to adult hemoglobin (HbA) but can bind oxygen with greater
affinity2. At birth, HbF accounts for around 75% of total hemoglobin, decreasing drastically at 4 months of age and reaching a
level close to zero in adult blood9. The absorption spectrum for fetal hemoglobin is very similar to adult hemoglobin, but the
absorption coefficients differ10, because of a hypsochromic shift in the oxygen dissociation curve of HbF compared to adult
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hemoglobin11. These small differences are the likely cause of reported inaccuracy in the spectrophotometric quantification of
HbCO in neonates12. Studies on this topic yield contradictory results. Vreman et al. 7 and Mehrotra et al. 8 report that spec-
trophotometric measurement of HbCO is falsely elevated by the presence of HbF, giving false positive results up to 8% when
using a CO-oximeter. Zwart et al. 13 and Variend et al. 14 report that in the method proposed by Katsumata et al. 4, reduction
of blood with sodium dithionite eliminates the interference of HbF, and thus should not give positive bias when using a basic
spectrophotometer. In this paper, using the Katsumata et al. 4 method, the impact of the infant’s age on determination of HbCO
is studied in 35 cases under one year of age. Comparison between ante-mortem and postmortem blood samples is performed.
The effect of increasing the concentration of sodium dithionite, as well as increasing the incubation time, is also examined.
2 METHODS
2.1 Materials
Sodium carbonate (certified ACS, 100.0%) and sodium hydroxide (certified ACS, 99.0%) were obtained from Fisher Scientific
(Fair Lawn, NJ, USA). Sodium dithionite (technical grade, 85%) was obtained from Sigma-Aldrich (St. Louis, MO, USA). HbCO
standards were obtained from Instrumentation Laboratory (Bedford, MA, USA). A Perkin Elmer UV/Vis Spectrophotometer
Lambda 35 was used to perform the spectrophotometric analysis. Minitab 17 (Minitab Inc., State College, PA, USA) and Excel
(Microsoft, Redmond, WA, USA) were used to perform statistical calculations and generate plots.
2.2 Ante-mortem and post-mortem blood sampling
All infants studied were under 1 year of age. Ante-mortem venous blood samples (𝑛 = 16) were obtained from the pediatric
hospital as excess from routine blood work. Blood was collected in BD Vacutainer tubes (lavender cap) containing EDTA and
stored at 4 ◦C. In post-mortem cases (𝑛 = 19), femoral and cardiac blood, when available, were sampled during the autopsy
from infants who died in circumstances unrelated to the presence of carbon monoxide (e.g. shaken baby syndrome, dog attack,
co-sleeping). Femoral blood was collected through a disposable needle inserted in the femoral vein. The femoral vein was
unclamped during this operation and 1 to 10 mL of the available femoral blood was collected. Average femoral blood volume
collected was 2 mL. Samples were stored at 4 ◦C in BD Vacutainer tubes (grey cap) containing 100 mg sodium fluoride and
20 mg potassium oxalate. Cardiac blood samples consisted of pooled cardiac blood (left and right ventricles) that flowed out
of the heart after the aorta was sectioned. Average cardiac blood volume was 5 mL but ranged from 2 to 50 mL. Samples were
stored at 4 ◦C in Starplex Leakbuster polypropylene containers without any preservative. Given the short time interval between
the collection of the samples and the analysis (0–72 hours), no stability issue was expected.
2.3 Spectrophotometric quantification
The HbCO quantification method was based on the work of Katsumata et al. 4,15. Briefly, 50 𝜇L of blood was diluted in 5 mL of
1 mg/mL sodium carbonate and vortexed. Then 20 mg of sodium dithionite and 500 𝜇L of 1 N sodium hydroxide were added to
the solution, with vortexing after each addition. The sample was allowed to rest for approximately 1 minute between the addition
of sodium dithionite and that of NaOH. An aliquot of this solution was then transferred to a 1 cm path length disposable plastic
absorbance cell. The absorbance spectrum from 500 nm to 650 nm was obtained using a double-beam spectrophotometer, with
sodium carbonate solution as the reference sample. Absorbance maxima measured around 530 nm and 560 nm were used to
quantify HbCO using Equation 1.
HbCO (%) = (2.21 − 𝐴560∕𝐴530) × 79 (1)
The constants in Equation 1 were obtained empirically using prepared standards of 5%, 20% and 50% HbCO. This method
was validated according to ISO 17025 and CAN-P-1578 guidelines (Canadian guidelines for the accreditation of forensic testing
laboratories). Sodium dithionite should convert all forms of hemoglobin (e.g. hemoglobin, methemoglobin, oxyhemoglobin)
into reduced hemoglobin (HHb) except for carboxyhemoglobin, providing a uniform system of HbCO and HHb. The addition
of sodium hydroxide clears the turbidity of the sample and allows a better spectrophotometric separation of the peaks of reduced
hemoglobin and carboxyhemoglobin. The spectra of the two components combine to form two distinct peaks at 530 nm and
560 nm. The absorbance ratio of these two peaks changes linearly with HbCO concentration in blood.
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2.4 Evaluation of sodium dithionite impact
The impact of sodium dithionite on the reduction of blood was evaluated by varying the mass added and the time of incubation
after addition. Five samples from infants with a high %HbCO were analyzed according to the method described above except that
the mass of sodium dithionite added to the sample was tripled (60 mg) and the incubation time was extended to 5 or 30 minutes
after the addition and vortexing.
3 RESULTS
3.1 Quantification of HbCO in neonates
A typical spectrum of neonate blood is shown in Figure 1 . The calculated results for neonates studied are presented in Table 1 .
The apparent levels of HbCO in infants under 3 months of age (𝑛 = 30) varies between 4.3% and 26.9%, while it is under 5% in
infants between 4 and 11 months of age (𝑛 = 5) for both ante-mortem and post-mortem infants.
FIGURE 1 Absorption spectrum of a blood sample. (1) Peak absorbance of HbCO at 530 nm. (2) Peak absorbance of HHb at
560 nm.
Figure 2 shows that apparent HbCO decreases with age in both groups, and correlates with the expected decrease of fetal
hemoglobin concentration in blood9. Prediction lines at the 95% confidence level, which represents the range in which a single
new observation is likely to fall given the predictors, is also shown in Figure 2 . It shows that HbCO values of 14% to 34% can
be obtained at an age of 2 weeks, whereas this interval goes down to 0% to 21% at 3 months.
3.2 Impact of sodium dithionite
Results of the tests with sodium dithionite are shown in Table 2 for the 5 cases studied. No significant change from baseline
valuewas observedwhen increasing the quantity of sodium dithionite threefold and increasing the time of incubation to 5minutes
(𝑝 = 0.447) or 30 minutes (𝑝 = 0.101). The expected effect was that sodium dithionite would reduce HbF to HHb, therefore
eliminating the HbF interference. This would then translate to a lower level of measured HbCO. However, in the majority of
cases, an increase of the %HbCO was observed. This shows that sodium dithionite does not eliminate the HbF interference.
3.3 Comparison of ante-mortem and post-mortem cases
The first order slope was obtained by least squares linear regression for %HbCO value against age in post-mortem cases and in
ante-mortem cases. There was no significant difference between slopes of ante-mortem (𝑚 = −3.54) and post-mortem (𝑚 =
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TABLE 1 Results for HbCO (%) in infants.
−4.84) cases at a 95% confidence level (𝑝 = 0.56), showing that there is no significant difference in the rate of decrease of the
interference with age. Additionally, there is no significant difference between the y-intercept of ante-mortem (𝑏 = 22.0) and post-
mortem (𝑏 = 23.7) cases at a 95% confidence level (𝑝 = 0.46). In conjunction with the lack of significant difference between
the slopes, this shows that ante-mortem and post-mortem cases suffer from similar interference due to the presence of HbF.
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FIGURE 2 Quantified HbCO (%) in neonates of 0 to 11 months. Prediction interval lines are shown for the 0 to 3 months
regression.
TABLE 2 Comparison of %HbCO between expected values and new conditions of blood reduction by sodium dithionite in 5
cases.
3.4 Comparison of cardiac and femoral blood
A paired t-test was performed between cardiac and femoral HbCO (%). Results show that there is a significant difference (𝑝 =
0.042) in the concentration of HbCO at the 95% confidence level. However, the small number of cases (𝑛 = 9) where cardiac
and femoral blood were both available and the proximity of the p-value to the significance threshold (0.05) should be kept in
mind and temper the weight placed on these statistical conclusions. Further tests with larger sample sizes would be necessary
to assess any significant difference between the two types of blood.
4 DISCUSSION
4.1 Quantification of HbCO in neonates
Normal HbCO levels have been found to be below 1.5% for non-smokers and up to 15% for cigarette smokers16. The fact that
the apparent HbCO in infants under 3 months of age went up to 25% in this study strongly suggests that the results were biased
towards positive values due to the presence and interference of HbF. This study focused on neonates under 4 months of age,
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when the fetal hemoglobin proportion is higher9. Only 4 samples of infants aged from 4 months to 1 year were analyzed, there-
fore there is no sufficient experimental evidence to draw definitive conclusions regarding the measurement of HbCO in that age
range. However, after 4 months, there is a rapid transition from HbF to HbA. In the results presented here, this transition trans-
lated into a rapid decrease of the apparent HbCO concentration as the age of the neonate increased. Therefore, HbF interference
in HbCO measurements in infants of 4 months and older is unlikely. Prediction interval boundaries in Figure 2 showed the
range of HbCO concentrations likely to be measured in neonate blood from 0 to 4 months. Measurement of additional samples
would help refine these boundaries and help in the interpretation of HbCO measurements in neonate cases.
These results do not exclude other exogenous factors that could give rise to high levels of HbCO. HbF has a greater affinity with
CO than adult hemoglobin (2.5–3 times)17. If the babies were exposed to a smoking environment prior to death or hospitalisation,
it is likely that their HbCO level would be higher than normal. However, given that the half-life of carboxyhemoglobin is about
7 hours in fetal blood17,18, this should not be an issue for ante-mortem samples, since they came from children hospitalised in a
nonsmoking area. Given that the post-mortem results are not significantly different from ante-mortem results, we infer that, in
aggregate, the post-mortem cases did not present elevated HbCO levels due to environmental exposure.
4.2 Impact of sodium dithionite
Sodium dithionite is used to convert all forms of hemoglobin into reduced hemoglobin except for carboxyhemoglobin.
Variend et al. 14 reported that reduction of blood with sodium dithionite eliminates the interference of HbF and should eliminate
the positive bias. However, our results showed that addition of sodium dithionite did not completely eliminate the interference
from HbF. In order to verify that this was not due to slow reaction kinetics, the quantity of dithionite was tripled (60 mg for
50 𝜇L of blood) and incubation time was increased up to 30 minutes. The results did not change after these modifications. No
difference between Variend et al. protocol and the one used here was found to explain the discordant results. The one notable
difference is the alternative wavelengths used by some authors (534 nm and 579 nm instead of 530 nm and 560 nm). How-
ever, this is known to be a difference attributable to the absence of strong base (1 N NaOH) in the preparation, which shifts the
spectrum and thus the peaks of absorption15. The only conclusion is that sodium dithionite does not allow reduction of all fetal
hemoglobin and proper elimination of its interference.
4.3 Comparison of ante-mortem and post-mortem cases
No significant difference between the measurements in ante-mortem and post-mortem cases was found. Therefore, future studies
on the subject of HbCO in neonates could be conducted on ante-mortem blood, which is more easily available than post-mortem
specimens. This would allow a larger sampling of the population and a more complete statistical analysis.
4.4 Comparison of cardiac and femoral blood
No strong conclusion can be given as to whether there is a significant difference between the measurements in cardiac and
femoral blood in infants. Additional tests should be done on a larger sample size in order to indicate if pooled cardiac blood could
confidently be used to quantify HbCO in whole blood. This piece of information would be particularly important in neonate
cases, where the volume of available femoral blood is much reduced (average of 2 mL collected). Femoral blood could therefore
be kept for quantification of analytes more subject to post-mortem redistribution phenomena.
5 CONCLUSION
The false elevation of neonates’ carboxyhemoglobin, as determined by spectrophotometric measurements, is an important piece
of information for forensic toxicologists, coroners, pathologists and health professionals. It can help in the determination of the
cause of death, or in the use of an adequate treatment for carbon monoxide poisoning. Because of false positives, HbCO results
for newborns under 4 months of age must be interpreted with care. We showed that HbCO values of 14% to 34% are likely to
be obtained at 2 weeks of age, whereas this interval goes down to 0% to 21% at 3 months. Confirmation by a second method
(e.g. gas chromatography) is strongly recommended for more accurate measurements. Another option would be the use of a
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neonate specific calibration curve with the current spectrophotometric method. However, due to the rapid change in HbF levels
in neonates, this is a difficult technique to set up. Ideally, the spectrophotometric method should be modified to be resistant to
HbF interference.
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